Montreal Heart Institute


Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine

Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection;...

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death

There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative progression of SARS-CoV-2 symptoms leading to hospitalization and potentially death. Can a widely available, generic drug used for gout...

Pin It on Pinterest